HOME Top Market Reports Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home Care Setting) - Global Forecast to 2020

Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home Care Setting) - Global Forecast to 2020

By: marketsandmarkets.com
Publishing Date: August 2015
Report Code: MD 3680

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The injectable drug delivery market is expected to reach $574.8 Billion by 2020 from $326.1 Billion in 2015, growing at a CAGR of 12.0% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements are driving the growth of this market. On the other hand, alternative delivery methods such as oral and transdermal, safety concerns, and blood-borne infections are hindering the growth of this market.

North America dominates the market, accounting for a major market share in 2014. Factors such as increasing prevalence of chronic diseases such as cancer and diabetes, increased demand for self-injection devices particularly pen injectors, technological advancements, patient compliance, and presence of key market players in North America are driving the growth of this market.

Prominent players in the injectable drug delivery market include Becton, Dickinson and Company (U.S.), Baxter International Inc. (U.S.), Gerresheimer AG (Germany), Pfizer, Inc. (U.S.), Schott AG (Germany), Sandoz (Germany), Teva Pharmaceutical Industries Ltd. (Israel), and Eli Lilly and Company (U.S.).

Scope of the Report

This research report covers the injectable drug delivery market by type, therapeutic application, usage pattern, mode of administration, end user, and region.

By Type

  • Devices
    • Conventional Injection Devices
    • Self-injection Devices
    • Other Devices
  • Formulations
    • Conventional Drug Delivery Formulations
    • Novel Drug Delivery Formulations
    • Long-acting Formulations

By Therapeutic Application

  • Autoimmune Diseases
  • Hormonal Disorders
  • Oncology
  • Orphan Diseases
  • Other Therapeutic Applications

By Usage Pattern

  • Curative Care
  • Immunization
  • Other Usage Patterns

By Mode of Administration

  • Skin
  • Organs
  • Central Nervous System
  • Circulatory/Musculoskeletal System

By End User

  • Hospitals/Clinics
  • Home Care Settings
  • Research Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Other End Users

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    •  Spain
    • Rest of Europe
  • Asia
  • Rest of the World

Table of Contents

1 Introduction (Page No. - 23)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Market Stakeholders

2 Research Methodology (Page No. - 29)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Key Data From Secondary Sources
    2.4 Key Data From Primary Sources
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 36)

4 Premium Insights (Page No. - 39)
    4.1 Injectable Drug Delivery Market, By Formulation
    4.2 Injectable Drug Delivery Market, By Usage Pattern
    4.3 Injectable Drug Delivery Market, By Mode of Administration
    4.4 Injectable Drug Delivery Market, By Therapeutic Application
    4.5 Geographical Snapshot

5 Market Overview (Page No. - 43)
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 By Type
           5.2.2 By Therapeutic Application
           5.2.3 By Usage Pattern
           5.2.4 By Mode of Administration
           5.2.5 By End User
           5.2.6 By Region
    5.3 Market Dynamics
    5.4 Drivers
           5.4.1 Rising Prevalence of Chronic Diseases
           5.4.2 Increase in Demand for Self-Injection Devices
           5.4.3 Growth of the Biologics Market
           5.4.4 Technological Advancements
    5.5 Restraints
           5.5.1 Needlestick Injuries and Infections
    5.6 Opportunities
           5.6.1 Increase in Demand for Biosimilars and Generic Injectables
                    5.6.1.1 Biosimilars
                    5.6.1.2 Generic Injectables
           5.6.2 Contraceptive Injectables
    5.7 Challenges
           5.7.1 Product Recalls
           5.7.2 Regulatory Hurdles
           5.7.3 Stability of Products
           5.7.4 Sterility of Injections
           5.7.5 Preference for Other Modes of Drug Delivery

6 Injectable Drug Delivery Market, By Type (Page No. - 60)
    6.1 Introduction
    6.2 Devices
           6.2.1 Conventional Injection Devices
                    6.2.1.1 By Material
                               6.2.1.1.1 Glass
                               6.2.1.1.2 Plastic
                    6.2.1.2 By Product
                               6.2.1.2.1 Fillable Syringes
                               6.2.1.2.2 Prefilled Syringes
                    6.2.1.3 By Usability
                               6.2.1.3.1 Reusable Syringes
                               6.2.1.3.2 Disposable Syringes
           6.2.2 Self-Injection Devices
                    6.2.2.1 Needle-Free Injectors
                               6.2.2.1.1 By Product
                                            6.2.2.1.1.1 Fillable Needle-Free Injectors
                                            6.2.2.1.1.2 Prefilled Needle-Free Injectors
                               6.2.2.1.2 By Technology
                                            6.2.2.1.2.1 Jet-Based Needle-Free Injectors
                                            6.2.2.1.2.2 Spring-Based Needle-Free Injectors
                                            6.2.2.1.2.3 Laser-Powered Needle-Free Injectors
                                            6.2.2.1.2.4 Vibration-Based Needle-Free Injectors
                               6.2.2.1.3 By Usability
                                            6.2.2.1.3.1 Reusable Needle-Free Injectors
                                            6.2.2.1.3.2 Disposable Needle-Free Injectors
                    6.2.2.2 Autoinjectors
                               6.2.2.2.1 By Product
                                            6.2.2.2.1.1 Fillable Autoinjectors
                                            6.2.2.2.1.2 Prefilled Autoinjectors
                               6.2.2.2.2 By Technology
                                            6.2.2.2.2.1 Automated Autoinjectors
                                            6.2.2.2.2.2 Manual Autoinjectors
                               6.2.2.2.3 By Design
                                            6.2.2.2.3.1 Standardized Autoinjectors
                                            6.2.2.2.3.2 Customized Autoinjectors
                               6.2.2.2.4 By Usability
                                            6.2.2.2.4.1 Reusable Autoinjectors
                                            6.2.2.2.4.2 Disposable Autoinjectors
                    6.2.2.3 Pen Injectors
                               6.2.2.3.1 By Product
                                            6.2.2.3.1.1 Single-Chambered Pen Injectors
                                            6.2.2.3.1.2 Dual-Chambered Pen Injectors
                               6.2.2.3.2 By Design
                                            6.2.2.3.2.1 Standard Pen Injectors
                                            6.2.2.3.2.2 Customized Pen Injectors
                               6.2.2.3.3 By Usability
                                            6.2.2.3.3.1 Reusable Pen Injectors
                                            6.2.2.3.3.2 Disposable Pen Injectors
                    6.2.2.4 Wearable Injectors
                    6.2.2.5 Other Devices
    6.3 Formulations
           6.3.1 Conventional Drug Delivery
                    6.3.1.1 Solutions
                    6.3.1.2 Reconstituted/Lyophilized Formulations
                    6.3.1.3 Suspensions
                    6.3.1.4 Emulsions
           6.3.2 Novel Drug Delivery Formulations
                    6.3.2.1 Colloidal Dispersions
                               6.3.2.1.1 Liposomes
                               6.3.2.1.2 Niosomes
                               6.3.2.1.3 Polymeric/Mixed Micelles
                               6.3.2.1.4 Nanoparticles
                                            6.3.2.1.4.1 Nanosuspensions
                                            6.3.2.1.4.2 Nanoemulsions/Microemulsions
                                            6.3.2.1.4.3 Solid-Lipid Nanoparticles
                    6.3.2.2 Microparticles
                               6.3.2.2.1 Microspheres
                               6.3.2.2.2 Microcapsules
           6.3.3 Long-Acting Injection Formulations

7 Injectable Drug Delivery Market, By Therapeutic Application (Page No. - 110)
    7.1 Introduction
    7.2 Autoimmune Diseases
           7.2.1 Rheumatoid Arthritis
           7.2.2 Multiple Sclerosis
           7.2.3 Crohn’s Disease
           7.2.4 Psoriasis
           7.2.5 Other Autoimmune Diseases
    7.3 Hormonal Disorders
           7.3.1 Diabetes
           7.3.2 Anemia
           7.3.3 Reproductive Health Disease
           7.3.4 Antithrombotic/Thrombolytic Therapy
           7.3.5 Osteoporosis
           7.3.6 Growth Hormone Deficiency (GHD)
    7.4 Orphan Diseases
    7.5 Oncology
    7.6 Others
           7.6.1 Pain Management
           7.6.2 Allergy Treatment
           7.6.3 Aesthetic Treatments
           7.6.4 Hepatitis C
           7.6.5 Hemophilia

8 Injectable Drug Delivery Market, By Usage Pattern (Page No. - 133)
    8.1 Introduction
    8.2 Curative Care
    8.3 Immunization
    8.4 Other Usage Patterns (Blood Transfusion and Blood Products, and Contraceptives)

9 Injectable Drug Delivery Market, By Mode of Administration (Page No. - 138)
    9.1 Introduction
    9.2 Skin
    9.3 Circulatory/Musculoskeletal
    9.4 Organs
    9.5 Central Nervous System

10 Injectable Drug Delivery Market, By End User (Page No. - 143)
     10.1 Introduction
     10.2 Hospitals and Clinics
     10.3 Home Care Settings
     10.4 Research Laboratories
     10.5 Pharmaceutical and Biotechnology Companies
     10.6 Other End Users

11 Injectable Drug Delivery Market, By Region (Page No. - 150)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 France
             11.3.3 U.K.
             11.3.4 Italy
             11.3.5 Spain
             11.3.6 Rest of Europe (RoE)
     11.4 Asia
     11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. - 202)
     12.1 Overview
     12.2 Market Share Analysis
     12.3 Competitive Situations & Trends
             12.3.1 New Product Launches
             12.3.2 FDA Approvals
             12.3.3 Expansions and Investments
             12.3.4 Acquisitions
             12.3.5 Collaborations

13 Company Profiles (Page No. - 210)
     13.1 Introduction
     13.2 Baxter International, Inc.
             13.2.1 Business Overview
             13.2.2 Product Offerings
             13.2.3 Recent Developments
             13.2.4 MnM View
     13.3 Becton, Dickinson and Company
             13.3.1 Business Overview
             13.3.2 Product Offerings
             13.3.3 Recent Developments
             13.3.4 MnM View
     13.4 Gerresheimer AG
             13.4.1 Business Overview
             13.4.2 Products Offered
             13.4.3 Recent Developments
             13.4.4 MnM View
     13.5 Pfizer, Inc.
             13.5.1 Business Overview
             13.5.2 Products Offered
             13.5.3 Recent Developments
             13.5.4 MnM View
     13.6 Schott AG
             13.6.1 Business Overview
             13.6.2 Product Offerings
             13.6.3 Recent Developments
             13.6.4 MnM View
     13.7 Alkermes PLC
             13.7.1 Business Overview
             13.7.2 Products Offered
             13.7.3 Recent Developments
     13.8 ELI Lilly and Company
             13.8.1 Business Overview
             13.8.2 Products Offered
             13.8.3 Recent Developments
     13.9 Sandoz
             13.9.1 Business Overview
             13.9.2 Products Offered
             13.9.3 Recent Developments
     13.10 Terumo Corporation
             13.10.1 Business Overview
             13.10.2 Products Offered
             13.10.3 Recent Developments
     13.11 Teva Pharmaceutical Industries Ltd.
             13.11.1 Business Overview
             13.11.2 Product Offerings
             13.11.3 Recent Developments

14 Appendix (Page No. - 235)
     14.1 Insights From Industry Experts
     14.2 Discussion Guide
     14.3 Other Recent Developments
     14.4 Available Customizations
     14.5 RT: Real-Time Market Intelligence
     14.6 Related Reports


List of Tables (217 Tables)

Table 1 Examples of Technological Advancements (2013–2015)
Table 2 Rising Prevalence of Chronic Diseases Across the Globe is A Major Factor Driving Market Growth
Table 3 Needlestick Injuries and Infections are Major Factors Limiting the Growth of the Market
Table 4 Increase in Demand for Biosimilars Offers an Array of Opportunities for the Market
Table 5 Examples of Product Recalls (2010–2015)
Table 6 Product Recalls are A Significant Challenge for Market Growth
Table 7 Injectable Drug Delivery Market Size, By Type, 2013–2020 (USD Million)
Table 8 Injectable Drug Delivery Market Size, By Region, 2013–2020 (USD Million)
Table 9 Injectable Drug Delivery Devices Market Size, By Type, 2013–2020 (USD Million)
Table 10 Injectable Drug Delivery Devices Market Size, By Region, 2013–2020 (USD Million)
Table 11 Conventional Injection Devices Market Size, By Region, 2013–2020 (USD Million)
Table 12 Conventional Injection Devices Market Size, By Material, 2013–2020 (USD Million)
Table 13 Conventional Glass Injection Devices Market Size, By Region, 2013–2020 (USD Million)
Table 14 Conventional Plastic Injection Devices Market Size, By Region, 2013–2020 (USD Million)
Table 15 Conventional Injection Devices Market Size, By Product, 2013–2020 (USD Million)
Table 16 Conventional Fillable Injection Devices Market Size, By Region, 2013–2020 (USD Million)
Table 17 Conventional Prefilled Injection Devices Market Size, By Region,  2013–2020 (USD Million)
Table 18 Conventional Injection Devices Market Size, By Usability, 2013–2020 (USD Million)
Table 19 Conventional Reusable Injection Devices Market Size, By Region, 2013–2020 (USD Million)
Table 20 Conventional Disposable Injection Devices Market Size, By Region,  2013–2020 (USD Million)
Table 21 Self-Injection Devices Market Size, By Type, 2013–2020 (USD Million)
Table 22 Self-Injection Devices Market Size, By Region, 2013–2020 (USD Million)
Table 23 Needle-Free Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 24 Needle-Free Injectors Market Size, By Product, 2013–2020 (USD Million)
Table 25 Fillable Needle-Free Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 26 Prefilled Needle-Free Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 27 Needle-Free Injectors Market Size, By Technology, 2013–2020 (USD Million)
Table 28 Jet-Based Needle-Free Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 29 Spring-Based Needle-Free Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 30 Laser-Powered Needle-Free Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 31 Vibration-Based Needle-Free Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 32 Needle-Free Injectors Market Size, By Usability, 2013–2020 (USD Million)
Table 33 Reusable Needle-Free Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 34 Disposable Needle-Free Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 35 Autoinjector Devices Market Size, By Region, 2013–2020 (USD Million)
Table 36 Autoinjector Devices Market Size, By Product, 2013–2020 (USD Million)
Table 37 Fillable Autoinjector Devices Market Size, By Region, 2013–2020 (USD Million)
Table 38 Prefilled Autoinjector Devices Market Size, By Region, 2013–2020 (USD Million)
Table 39 Autoinjector Devices Market Size, By Technology, 2013–2020 (USD Million)
Table 40 Automated Autoinjectors Market Size, By Region, 2013–2020 (USD Million)
Table 41 Manual Autoinjectors Market Size, By Region, 2013–2020 (USD Million)
Table 42 Autoinjectors Market Size, By Design, 2013–2020 (USD Million)
Table 43 Standardized Autoinjectors Market Size, By Region, 2013–2020 (USD Million)
Table 44 Customized Autoinjectors Market Size, By Region, 2013–2020 (USD Million)
Table 45 Autoinjectors Market Size, By Usability, 2013–2020 (USD Million)
Table 46 Reusable Autoinjectors Market Size, By Region, 2013–2020 (USD Million)
Table 47 Disposable Autoinjectors Market Size, By Region, 2013–2020 (USD Million)
Table 48 Pen Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 49 Pen Injectors Market Size, By Product, 2013–2020 (USD Million)
Table 50 Single-Chambered Pen Injectors Market Size, By Region,  2013–2020 (USD Million)
Table 51 Dual-Chambered Pen Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 52 Pen Injectors Market Size, By Design, 2013–2020 (USD Million)
Table 53 Standard Pen Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 54 Customized Pen Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 55 Pen Injectors Market Size, By Usability, 2013–2020 (USD Million)
Table 56 Reusable Pen Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 57 Disposable Pen Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 58 Wearable Injectors Market Size, By Region, 2013–2020 (USD Million)
Table 59 Other Devices Market Size, By Region, 2013–2020 (USD Million)
Table 60 Injectable Drug Delivery Formulations Market Size, By Type, 2013–2020 (USD Million)
Table 61 Injectable Drug Delivery Formulations Market Size, By Region, 2013–2020 (USD Million)
Table 62 Conventional Drug Delivery Formulations Market Size, By Type, 2013–2020 (USD Million)
Table 63 Conventional Drug Delivery Formulations Market Size, By Region,  2013–2020 (USD Million)
Table 64 Solutions Market Size, By Region, 2013–2020 (USD Million)
Table 65 Reconstituted/Lyophilized Formulations Market Size, By Region, 2013–2020 (USD Million)
Table 66 Suspensions Market Size, By Region, 2013–2020 (USD Million)
Table 67 Emulsions Market Size, By Region, 2013–2020 (USD Million)
Table 68 Novel Drug Delivery Formulations Market Size, By Type, 2013–2020 (USD Million)
Table 69 Novel Drug Delivery Formulations Market Size, By Region, 2013–2020 (USD Million)
Table 70 Colloidal Dispersion Market Size, By Type, 2013–2020 (USD Million)
Table 71 Colloidal Dispersion Market Size, By Region, 2013–2020 (USD Million)
Table 72 Liposomes Market Size, By Region, 2013–2020 (USD Million)
Table 73 Niosomes Market Size, By Region, 2013–2020 (USD Million)
Table 74 Polymeric/Mixed Micelles Market Size, By Region, 2013–2020 (USD Million)
Table 75 Nanoparticles Market Size, By Type, 2013–2020 (USD Million)
Table 76 Nanoparticles Market Size, By Region, 2013–2020 (USD Million)
Table 77 Nanosuspensions Market Size, By Region, 2013–2020 (USD Million)
Table 78 Nanoemulsions/Microemulsions Market Size, By Region, 2013–2020 (USD Million)
Table 79 Solid-Lipid Nanoparticles Market Size, By Region, 2013–2020 (USD Million)
Table 80 Microparticles Market Size, By Type, 2013–2020 (USD Million)
Table 81 Microparticles Market Size, By Region, 2013–2020 (USD Million)
Table 82 Microspheres Market Size, By Region, 2013–2020 (USD Million)
Table 83 Microcapsules Market Size, By Region, 2013–2020 (USD Million)
Table 84 Long-Acting Injection Formulations Market Size, By Region, 2013–2020 (USD Million)
Table 85 Injectable Drug Delivery Market Size, By Therapeutic Application, 2013–2020 (USD Million)
Table 86 Injectable Drug Delivery Market Size for Autoimmune Diseases, By Indication, 2013–2020 (USD Million)
Table 87 Injectable Drug Delivery Market Size for Autoimmune Diseases Market Size, By Region, 2013–2020 (USD Million)
Table 88 Injectable Drug Delivery Market Size for Rheumatoid Arthritis, By Region, 2013–2020 (USD Million)
Table 89 Injectable Drug Delivery Market Size for Multiple Sclerosis, By Region, 2013–2020 (USD Million)
Table 90 Injectable Drug Delivery Market Size for Crohn’s Disease, By Region, 2013–2020 (USD Million)
Table 91 Injectable Drug Delivery Market Size for Psoriasis, By Region, 2013–2020 (USD Million)
Table 92 Injectable Drug Delivery Market Size for Other Autoimmune Diseases,  By Region, 2013–2020 (USD Million)
Table 93 Injectable Drug Delivery Market Size for Hormonal Disorders, By Indication, 2013–2020 (USD Million)
Table 94 Injectable Drug Delivery Market Size for Hormonal Disorders, By Region, 2013–2020 (USD Million)
Table 95 Injectable Drug Delivery Market Size for Diabetes, By Region, 2013–2020 (USD Million)
Table 96 Injectable Drug Delivery Market Size for Anemia, By Region, 2013–2020 (USD Million)
Table 97 Injectable Drug Delivery Market Size for Reproductive Health Disease, By Region, 2013–2020 (USD Million)
Table 98 Injectable Drug Delivery Market Size for Antithrombotic/Thrombolytic Therapy, By Region, 2013–2020 (USD Million)
Table 99 Injectable Drug Delivery Market Size for Osteoporosis, By Region,  2013-2020 (USD Million)
Table 100 Injectable Drug Delivery Market Size for Growth Hormone Deficiency (GHD), By Region, 2013-2020 (USD Million)
Table 101 Injectable Drug Delivery Market Size for Orphan Diseases, By Region, 2013-2020 (USD Million)
Table 102 Injectable Drug Delivery Market Size for Oncology, By Region, 2013-2020 (USD Million)
Table 103 Injectable Drug Delivery Market Size for Other Therapeutic Applications, By Indication, 2013-2020 (USD Million)
Table 104 Injectable Drug Delivery Market Size for Other Therapeutic Applications,  By Region, 2013-2020 (USD Million)
Table 105 Injectable Drug Delivery Market Size for Pain Management, By Region,  2013-2020 (USD Million)
Table 106 Injectable Drug Delivery Market Size for Allergy Treatment, By Region,  2013-2020 (USD Million)
Table 107 Injectable Drug Delivery Market Size for Aesthetic Treatments, By Region, 2013-2020 (USD Million)
Table 108 Injectable Drug Delivery Market Size for Hepatitis C, By Region, 2013-2020 (USD Million)
Table 109 Injectable Drug Delivery Market Size for Hemophilia, By Region, 2013-2020 (USD Million)
Table 110 Injectable Drug Delivery Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 111 Curative Care Market Size, By Region, 2013-2020 (USD Million)
Table 112 Immunization Market Size, By Region, 2013-2020 (USD Million)
Table 113 Other Usage Patterns Market Size, By Region, 2013–2020 (USD Million)
Table 114 Injectable Drug Delivery Market Size, By Mode of Administration,  2013—2020 (USD Million)
Table 115 Skin Administration Market Size, By Region, 2013—2020 (USD Million)
Table 116 Circulatory/Musculoskeletal Administration Market Size, By Region,  2013—2020 (USD Million)
Table 117 Organ Administration Market Size, By Region, 2013—2020 (USD Million)
Table 118 Central Nervous System Administration Market Size, By Region, 2013—2020 (USD Million)
Table 119 Injectable Drug Delivery Market Size, By End User, 2013-2020 (USD Million)
Table 120 Injectable Drug Delivery Market Size, By Region, 2013-2020 (USD Million)
Table 121 Hospitals and Clinics Market Size, By Region, 2013-2020 (USD Million)
Table 122 Home Care Settings Market Size, By Region, 2013-2020 (USD Million)
Table 123 Research Laboratories Market Size, By Region, 2013-2020 (USD Million)
Table 124 Pharmaceutical and Biotechnology Companies Market Size, By Region,  2013-2020 (USD Million)
Table 125 Other End Users Market Size, By Region, 2013-2020 (USD Million)
Table 126 Injectable Drug Delivery Market Size, By Region, 2013-2020 (USD Million)
Table 127 North America: Injectable Drug Delivery Market Size, By Country,  2013-2020 (USD Million)
Table 128 North America: Market Size, By Type, 2013–2020 (USD Million)
Table 129 North America: Market Size, By Device, 2013–2020 (USD Million)
Table 130 North America: Market Size, By Formulation,  2013-2020 (USD Million)
Table 131 North America: Market Size, By Therapeutic Application, 2013–2020 (USD Million)
Table 132 North America: Market Size, By Usage Pattern,  2013–2020 (USD Million)
Table 133 North America: Market Size, By Mode of Administration, 2013–2020 (USD Million)
Table 134 North America: Market Size, By End User,  2013–2020 (USD Million)
Table 135 U.S.: Market Size, By Type, 2013–2020 (USD Million)
Table 136 U.S.: Market Size, By Device, 2013–2020 (USD Million)
Table 137 U.S.: Market Size, By Formulation, 2013-2020 (USD Million)
Table 138 U.S.: Market Size, By Therapeutic Application,  2013–2020 (USD Million)
Table 139 U.S.: Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 140 U.S.: Market Size, By Mode of Administration,  2013–2020 (USD Million)
Table 141 U.S.: Market Size, By End User, 2013–2020 (USD Million)
Table 142 Canada: Market Size, By Type, 2013–2020 (USD Million)
Table 143 Canada: Market Size, By Device, 2013–2020 (USD Million)
Table 144 Canada: Market Size, By Formulation, 2013-2020 (USD Million)
Table 145 Canada: Market Size, By Therapeutic Application, 2013–2020 (USD Million)
Table 146 Canada: Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 147 Canada: Market Size, By Mode of Administration, 2013–2020 (USD Million)
Table 148 Canada: Market Size, By End User, 2013–2020 (USD Million)
Table 149 Europe: Market Size, By Country, 2013-2020 (USD Million)
Table 150 Europe: Market Size, By Type, 2013–2020 (USD Million)
Table 151 Europe: Market Size, By Device, 2013–2020 (USD Million)
Table 152 Europe: Market Size, By Formulation, 2013-2020 (USD Million)
Table 153 Europe: Market Size, By Therapeutic Application, 2013–2020 (USD Million)
Table 154 Europe: Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 155 Europe: Market Size, By Mode of Administration, 2013–2020 (USD Million)
Table 156 Europe: Market Size, By End User, 2013–2020 (USD Million)
Table 157 Germany: Market Size, By Type, 2013-2020 (USD Million)
Table 158 Germany: Market Size, By Device, 2013-2020 (USD Million)
Table 159 Germany: Market Size, By Formulation, 2013–2020 (USD Million)
Table 160 Germany: Market Size, By Therapeutic Application, 2013–2020 (USD Million)
Table 161 Germany: Market Size, By Usage Pattern,  2013–2020 (USD Million)
Table 162 Germany: Market Size, By Mode of Administration, 2013–2020 (USD Million)
Table 163 Germany: Market Size, By End User, 2013–2020 (USD Million)
Table 164 France: Market Size, By Type, 2013–2020 (USD Million)
Table 165 France: Market Size, By Device, 2013–2020 (USD Million)
Table 166 France: Market Size, By Formulation, 2013-2020 (USD Million)
Table 167 France: Market Size, By Therapeutic Application, 2013–2020 (USD Million)
Table 168 France: Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 169 France: Market Size, By Mode of Administration, 2013–2020 (USD Million)
Table 170 France: Market Size, By End User, 2013–2020 (USD Million)
Table 171 U.K.: Market Size, By Type, 2013-2020 (USD Million)
Table 172 U.K.: Market Size, By Device, 2013-2020 (USD Million)
Table 173 U.K.: Market Size, By Formulation, 2013-2020 (USD Million)
Table 174 U.K.: Market Size, By Therapeutic Application,  2013-2020 (USD Million)
Table 175 U.K.: Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 176 U.K.: Market Size, By Mode of Administration,  2013–2020 (USD Million)
Table 177 U.K.: Market Size, By End User, 2013–2020 (USD Million)
Table 178 Italy: Market Size, By Type, 2013–2020 (USD Million)
Table 179 Italy: Market Size, By Device, 2013–2020 (USD Million)
Table 180 Italy: Market Size, By Formulation, 2013–2020 (USD Million)
Table 181 Italy: Market Size, By Therapeutic Application,  2013–2020 (USD Million)
Table 182 Italy: Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 183 Italy: Market Size, By Mode of Administration,  2013–2020 (USD Million)
Table 184 Italy: Market Size, By End User, 2013–2020 (USD Million)
Table 185 Spain: Market Size, By Type, 2013–2020 (USD Million)
Table 186 Spain: Market Size, By Device, 2013–2020 (USD Million)
Table 187 Spain: Market Size , By Formulation, 2013-2020 (USD Million)
Table 188 Spain: Market Size, By Therapeutic Application, 2013–2020 (USD Million)
Table 189 Spain: Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 190 Spain: Market Size, By Mode of Administration, 2013–2020 (USD Million)
Table 191 Spain: Market Size, By End User, 2013–2020 (USD Million)
Table 192 RoE: Market Size, By Type, 2013–2020 (USD Million)
Table 193 RoE: Market Size, By Device, 2013–2020 (USD Million)
Table 194 RoE: Market Size, By Formulation, 2013-2020 (USD Million)
Table 195 RoE: Market Size, By Therapeutic Application,  2013–2020 (USD Million)
Table 196 RoE: Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 197 RoE: Market Size, By Mode of Administration,  2013–2020 (USD Million)
Table 198 RoE: Market Size, By End User, 2013–2020 (USD Million)
Table 199 Asia: Market Size, By Type, 2013–2020 (USD Million)
Table 200 Asia: Market Size, By Device, 2013–2020 (USD Million)
Table 201 Asia: Market Size, By Formulation, 2013-2020 (USD Million)
Table 202 Asia: Market Size, By Therapeutic Application,  2013–2020 (USD Million)
Table 203 Asia: Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 204 Asia: Market Size, By Mode of Administration,  2013–2020 (USD Million)
Table 205 Asia: Market Size, By End User, 2013–2020 (USD Million)
Table 206 RoW: Market Size, By Type, 2013–2020 (USD Million)
Table 207 RoW: Market Size, By Device, 2013–2020 (USD Million)
Table 208 RoW: Market Size, By Formulation, 2013-2020 (USD Million)
Table 209 RoW: Market Size, By Therapeutic Application,  2013–2020 (USD Million)
Table 210 RoW: Market Size, By Usage Pattern, 2013–2020 (USD Million)
Table 211 RoW: Market Size, By Mode of Administration, 2013–2020 (USD Million)
Table 212 RoW: Market Size, By End User, 2013–2020 (USD Million)
Table 213 New Product Launches, 2012–2015
Table 214 FDA Approvals, 2012–2015
Table 215 Expansions and Investments, 2012–2015
Table 216 Acquisitions, 2012–2015
Table 217 Collaborations, 2012–2015


List of Figures (47 Figures)

Figure 1 Research Design
Figure 2 Market Size Estimation: Bottom-Up Approach
Figure 3 Market Size Estimation: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation,  and Region
Figure 5 Data Triangulation Methodology
Figure 6 Injectable Drug Delivery Market, By Formulation, 2015 vs 2020
Figure 7 Injectable Drug Delivery Market, By Device, 2015 vs 2020
Figure 8 Hospitals and Clinics to Form the Largest End-User Segment
Figure 9 Injectable Drug Delivery Market, By Therapeutic Application, 2015 vs 2020
Figure 10 Injectable Drug Delivery Formulations Market to Grow at the Highest CAGR From 2015 to 2020
Figure 11 The Curative Care Segment to Witness the Highest Growth Rate in the Forecast Period
Figure 12 Skin Segment to Account for the Largest Share in 2015
Figure 13 Hormonal Disorders Segment to Account for the Largest Share in 2015
Figure 14 Asia to Witness Highest Growth Rate During the Forecast Period
Figure 15 Market Segmentation, By Type
Figure 16 Market Segmentation, By Therapeutic Application
Figure 17 Market Segmentation, By Usage Pattern
Figure 18 Market Segmentation, By Mode of Administration
Figure 19 Market Segmentation, By End User
Figure 20 Market Segmentation, By Region
Figure 21 Drivers, Restraints, Opportunities, and Challenges of the Injectable Drug Delivery Market
Figure 22 Injectable Drug Delivery Therapeutic Applications Market, By Region, 2013–2020 (USD Million)
Figure 23 Therapeutic Applications: Oncology to Show Highest Growth During the Forecast Period
Figure 24 Injectable Drug Delivery Market, By Usage Pattern: Curative Care Segment to Hold Largest Share
Figure 25 Injectable Drug Delivery Market, By Mode of Administration: Skin Segment to Show Highest Growth
Figure 26 Market Segmentation, By End User
Figure 27 Injectable Drug Delivery Market, By End User: Hospitals and Clinics to Hold Largest Market Share in 2015
Figure 28 North America to Hold the Largest Share of the Global Market (2015)
Figure 29 European Injectable Drug Delivery Market Snapshot (2015)
Figure 30 RoE: Self-Injection Devices Market Snapshot
Figure 31 Asia to Be the Fastest-Growing Regional Segment of the Global Injectable Drug Delivery Market (2015)
Figure 32 Rising Prevalence of Chronic Diseases to Drive the Growth of the Injectable Drug Delivery Market in the RoW (2015)
Figure 33 New Product Launches, Key Growth Strategy Between 2012 & 2015
Figure 34 Market Share, By Key Player (2014)
Figure 35 Market Evolution Framework: Partnerships, AGreements, and Collaborations & Expansions are Fueling Market Growth
Figure 36 Battle for Market Share: New Product Launches Was the Key Strategy Adopted By Leading Players, 2014
Figure 37 Product Benchmarking for Top 5 Players
Figure 38 Baxter International, Inc.: Company Snapshot
Figure 39 Becton, Dickinson and Company: Company Snapshot
Figure 40 Gerresheimer AG: Company Snapshot
Figure 41 Pfizer, Inc.: Company Snapshot
Figure 42 Schott AG: Company Snapshot
Figure 43 Alkermes PLC: Company Snapshot
Figure 44 ELI Lilly and Company: Company Snapshot
Figure 45 Sandoz: Company Snapshot
Figure 46 Terumo Corporation: Company Snapshot
Figure 47 Teva Pharmaceutical Industries Ltd.: Company Snapshot

Injectable drug delivery offers a promising alternative for the delivery of drugs that are ineffective when administered orally. Injectable drug delivery is aimed to maximize patient compliance and reduce the frequency of dosage administration without compromising the effectiveness of the treatment.

The major factors responsible for the growth of the injectable drug delivery market are the rising prevalence of chronic diseases, growth of the biologics market, rising demand for self-injection devices, and technological advancements. Owing to these factors, the demand for devices such as safety syringes, prefilled syringes, and auto-disabled syringes is increasing. On the other hand, alternative methods such as oral and transdermal delivery, safety concerns, and risk of blood-borne infections are expected to restrain the growth of this market.

The injectable drug delivery market is expected to reach $574.8 Billion by 2020 from $326.2 Billion in 2015, growing at a CAGR of 12.0% from 2015 to 2020. Based on type, the market is segmented into devices and formulations. The devices market is further segmented into conventional injection devices, self-injections, and other devices. The formulations market is further segmented into conventional drug delivery formulations, novel drug delivery formulations, and long-acting injection formulations.

On the basis of therapeutic application, the injectable drug delivery market is segmented into autoimmune diseases, hormonal disorders, oncology, orphan diseases, and other diseases. On the basis of usage pattern, the market is segmented into curative care, immunization, and others.

On the basis of mode of administration, the market is segmented into skin, organs, central nervous system, and circulatory/musculoskeletal system. On the basis of end user, the market is segmented into hospitals/clinics, home care setting, research laboratories, pharma and biotech companies, and other end users.

Key players in the injectable drug delivery market include Becton, Dickinson and Company (U.S.), Baxter International, Inc. (U.S.), Gerresheimer AG (Germany), Pfizer, Inc. (U.S.), Schott AG (Germany), Sandoz (Germany), Teva Pharmaceutical Industries Ltd. (Israel), and Eli Lilly and Company (U.S.).

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports